Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 2
1988 3
1989 1
1990 1
1991 6
1992 2
1993 1
1994 1
1995 4
1996 1
1997 4
1998 6
1999 5
2000 3
2001 3
2002 5
2003 4
2004 4
2005 4
2006 1
2007 5
2008 1
2009 5
2010 6
2011 6
2012 7
2013 11
2014 8
2015 7
2016 8
2017 4
2018 4
2019 5
2020 10
2021 8
2022 4
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Results by year

Filters applied: . Clear all
Page 1
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, Boletis J, Bruce IN, Cervera R, Doria A, Dörner T, Furie RA, Gladman DD, Houssiau FA, Inês LS, Jayne D, Kouloumas M, Kovács L, Mok CC, Morand EF, Moroni G, Mosca M, Mucke J, Mukhtyar CB, Nagy G, Navarra S, Parodis I, Pego-Reigosa JM, Petri M, Pons-Estel BA, Schneider M, Smolen JS, Svenungsson E, Tanaka Y, Tektonidou MG, Teng YO, Tincani A, Vital EM, van Vollenhoven RF, Wincup C, Bertsias G, Boumpas DT. Fanouriakis A, et al. Among authors: houssiau fa. Ann Rheum Dis. 2024 Jan 2;83(1):15-29. doi: 10.1136/ard-2023-224762. Ann Rheum Dis. 2024. PMID: 37827694
2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, Boletis J, Frangou E, Houssiau FA, Hollis J, Karras A, Marchiori F, Marks SD, Moroni G, Mosca M, Parodis I, Praga M, Schneider M, Smolen JS, Tesar V, Trachana M, van Vollenhoven RF, Voskuyl AE, Teng YKO, van Leew B, Bertsias G, Jayne D, Boumpas DT. Fanouriakis A, et al. Among authors: houssiau fa. Ann Rheum Dis. 2020 Jun;79(6):713-723. doi: 10.1136/annrheumdis-2020-216924. Epub 2020 Mar 27. Ann Rheum Dis. 2020. PMID: 32220834
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R. Houssiau FA, et al. Arthritis Rheum. 2002 Aug;46(8):2121-31. doi: 10.1002/art.10461. Arthritis Rheum. 2002. PMID: 12209517 Free article. Clinical Trial.
2021 DORIS definition of remission in SLE: final recommendations from an international task force.
van Vollenhoven RF, Bertsias G, Doria A, Isenberg D, Morand E, Petri MA, Pons-Estel BA, Rahman A, Ugarte-Gil MF, Voskuyl A, Arnaud L, Bruce IN, Cervera R, Costedoat-Chalumeau N, Gordon C, Houssiau FA, Mosca M, Schneider M, Ward MM, Alarcon G, Aringer M, Askenase A, Bae SC, Bootsma H, Boumpas DT, Brunner H, Clarke AE, Coney C, Czirják L, Dörner T, Faria R, Fischer R, Fritsch-Stork R, Inanc M, Jacobsen S, Jayne D, Kuhn A, van Leeuw B, Limper M, Mariette X, Navarra S, Nikpour M, Olesinska MH, Pons-Estel G, Romero-Diaz J, Rubio B, Schoenfeld Y, Bonfá E, Smolen J, Teng YKO, Tincani A, Tsang-A-Sjoe M, Vasconcelos C, Voss A, Werth VP, Zakharhova E, Aranow C. van Vollenhoven RF, et al. Among authors: houssiau fa. Lupus Sci Med. 2021 Nov;8(1):e000538. doi: 10.1136/lupus-2021-000538. Lupus Sci Med. 2021. PMID: 34819388 Free PMC article.
Prediction of prognosis and renal outcome in lupus nephritis.
Parodis I, Tamirou F, Houssiau FA. Parodis I, et al. Among authors: houssiau fa. Lupus Sci Med. 2020 Feb 18;7(1):e000389. doi: 10.1136/lupus-2020-000389. eCollection 2020. Lupus Sci Med. 2020. PMID: 32153796 Free PMC article. Review.
Management of Lupus Nephritis.
Tamirou F, Houssiau FA. Tamirou F, et al. Among authors: houssiau fa. J Clin Med. 2021 Feb 9;10(4):670. doi: 10.3390/jcm10040670. J Clin Med. 2021. PMID: 33572385 Free PMC article. Review.
[Treatment of lupus nephritis].
Houssiau FA. Houssiau FA. Biol Aujourdhui. 2024;218(1-2):25-31. doi: 10.1051/jbio/2024006. Epub 2024 Jul 15. Biol Aujourdhui. 2024. PMID: 39007774 Review. French.
New Treatment Options in Lupus Nephritis.
Montigny PM, Houssiau FA. Montigny PM, et al. Among authors: houssiau fa. Arch Immunol Ther Exp (Warsz). 2022 Mar 17;70(1):11. doi: 10.1007/s00005-022-00647-8. Arch Immunol Ther Exp (Warsz). 2022. PMID: 35298708 Review.
Effect of Belimumab on Preventing de novo Renal Lupus Flares.
Parodis I, Lindblom J, Cetrez N, Palazzo L, Ala H, Houssiau FA, Sjöwall C, Rovin BH. Parodis I, et al. Among authors: houssiau fa. Kidney Int Rep. 2023 Jul 6;8(9):1822-1830. doi: 10.1016/j.ekir.2023.06.021. eCollection 2023 Sep. Kidney Int Rep. 2023. PMID: 37705915 Free PMC article.
150 results